Targeted-release budesonide in recurrent IgA nephropathy after kidney transplantation

Kidney Int. 2023 May;103(5):995-996. doi: 10.1016/j.kint.2023.02.012.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Budesonide / therapeutic use
  • Glomerulonephritis, IGA* / drug therapy
  • Humans
  • Kidney Transplantation* / adverse effects

Substances

  • Budesonide